中华结直肠疾病电子杂志
中華結直腸疾病電子雜誌
중화결직장질병전자잡지
Chinese Journal of Colorectal Diseases
2015年
5期
505-510
,共6页
黄跃南%宁丽%李云龙%游柳平%王春敬%刘家麒
黃躍南%寧麗%李雲龍%遊柳平%王春敬%劉傢麒
황약남%저려%리운룡%유류평%왕춘경%류가기
结直肠肿瘤%抗药性,肿瘤%奥沙利铂%LAPTM4β
結直腸腫瘤%抗藥性,腫瘤%奧沙利鉑%LAPTM4β
결직장종류%항약성,종류%오사리박%LAPTM4β
Colorectal neoplasms%Drug resistance,neoplasm%Oxaliplatin%LAPTM4β
目的:建立耐奥沙利铂( L-OHP)的人结直肠癌耐药细胞株( HT-29/L-OHP),检测相关耐药基因LAPTM4β的表达,探讨其在L-OHP耐药中的作用机制。方法采用药物浓度梯度递增间歇诱导法建立人结直肠癌耐药株HT-29/L-OHP;应用LAPTM4β-35蛋白抑制剂作用于HT-29/L-OHP细胞株后,流式细胞技术检测细胞凋亡,比较其与HT-29/L-OHP细胞株对于L-OHP的耐药情况;应用RT-PCR检测LAPTM4βmRNA的表达;应用Western blot测定LAPTM4β-35蛋白的表达。结果成功建立人结直肠癌耐药细胞株HT-29/L-OHP,流式细胞技术检测结果表明应用LAPTM4β-35蛋白抑制剂作用于HT-29/L-OHP细胞株后,其对于L-OHP的耐药明显低于HT-29/L-OHP细胞株。 HT-29/L-OHP细胞株中LAPTM4βmRNA表达水平明显高于亲本细胞株HT-29,分别为5.613±0.139和1.105±0.187,(P<0.05),LAPTM4β-35蛋白在HT-29/L-OHP细胞和HT-29细胞的相对表达量2.203±0.080和1.033±0.070,(P<0.05)。结论 LAPTM4β在结直肠癌耐药细胞株中过表达,与结直肠癌奥沙利铂耐药密切相关,可以作为结直肠癌耐药的一个敏感的生物学标志物。
目的:建立耐奧沙利鉑( L-OHP)的人結直腸癌耐藥細胞株( HT-29/L-OHP),檢測相關耐藥基因LAPTM4β的錶達,探討其在L-OHP耐藥中的作用機製。方法採用藥物濃度梯度遞增間歇誘導法建立人結直腸癌耐藥株HT-29/L-OHP;應用LAPTM4β-35蛋白抑製劑作用于HT-29/L-OHP細胞株後,流式細胞技術檢測細胞凋亡,比較其與HT-29/L-OHP細胞株對于L-OHP的耐藥情況;應用RT-PCR檢測LAPTM4βmRNA的錶達;應用Western blot測定LAPTM4β-35蛋白的錶達。結果成功建立人結直腸癌耐藥細胞株HT-29/L-OHP,流式細胞技術檢測結果錶明應用LAPTM4β-35蛋白抑製劑作用于HT-29/L-OHP細胞株後,其對于L-OHP的耐藥明顯低于HT-29/L-OHP細胞株。 HT-29/L-OHP細胞株中LAPTM4βmRNA錶達水平明顯高于親本細胞株HT-29,分彆為5.613±0.139和1.105±0.187,(P<0.05),LAPTM4β-35蛋白在HT-29/L-OHP細胞和HT-29細胞的相對錶達量2.203±0.080和1.033±0.070,(P<0.05)。結論 LAPTM4β在結直腸癌耐藥細胞株中過錶達,與結直腸癌奧沙利鉑耐藥密切相關,可以作為結直腸癌耐藥的一箇敏感的生物學標誌物。
목적:건립내오사리박( L-OHP)적인결직장암내약세포주( HT-29/L-OHP),검측상관내약기인LAPTM4β적표체,탐토기재L-OHP내약중적작용궤제。방법채용약물농도제도체증간헐유도법건립인결직장암내약주HT-29/L-OHP;응용LAPTM4β-35단백억제제작용우HT-29/L-OHP세포주후,류식세포기술검측세포조망,비교기여HT-29/L-OHP세포주대우L-OHP적내약정황;응용RT-PCR검측LAPTM4βmRNA적표체;응용Western blot측정LAPTM4β-35단백적표체。결과성공건립인결직장암내약세포주HT-29/L-OHP,류식세포기술검측결과표명응용LAPTM4β-35단백억제제작용우HT-29/L-OHP세포주후,기대우L-OHP적내약명현저우HT-29/L-OHP세포주。 HT-29/L-OHP세포주중LAPTM4βmRNA표체수평명현고우친본세포주HT-29,분별위5.613±0.139화1.105±0.187,(P<0.05),LAPTM4β-35단백재HT-29/L-OHP세포화HT-29세포적상대표체량2.203±0.080화1.033±0.070,(P<0.05)。결론 LAPTM4β재결직장암내약세포주중과표체,여결직장암오사리박내약밀절상관,가이작위결직장암내약적일개민감적생물학표지물。
Objective To establish L-OHP resistant human colorectal cancer cell line ( HT-29/L-OHP) , and detect the expression of related drug resistant gene LAPTM 4β, and probe its role in the mechanism of L-OHP resistant.Method Drug concentration gradient increasing intermittent induction method was used to establish L-OHP resistant human colorectal cancer cell line ( HT-29/L-OHP );LAPTM4β-35 protein inhibitor was used in HT-29/L-OHP cell line ,flow cytometry was adopted to detect cell apoptosis,and to compare L-OHP resistant of it with other HT-29/L-OHP cell line;RT-PCR was adopted to detect the expression of LAPTM 4βmRNA;Western blot was used to detect the expression of LAPTM 4β-35 protein.Result L-OHP resistant human colorectal cancer cell line ( HT-29/L-OHP ) was established successfully .The flow cytometry result showed that LAPTM 4β-35 protein inhibitor use in HT-29/L-OHP cell line lead to significantly lower L-OHP resistance than that of HT-29/L-OHP cell line.The expression of LAPTM4βmRNA of HT-29/L-OHP was significantly higher than parental cell plant HT-29,5.613+0.139 and 1.105+0.187,respectively(P<0.05).The relative expression level of LAPTM4-35 in HT-29/L-OHP cell line and HT-29 cell line was 2.203+0.080 and 1.033+0.070,(P<0.05).Conclusion LAPTM4βis overexpressed in HT-29/L-OHP cell line, and it is closely related with L-OHP resistant of colorectal cancer,it could be used as a sensitive biomarker for drug resistance of colorectal cancer .